Research Summaries

Smoking Associated with Increased Risk of Developing a Second Smoking-Related Cancer

According to an analysis published in the Journal of Clinical Oncology, patients and survivors who smoked prior to their cancer diagnosis had an up to five times higher risk of developing a second primary cancer than patients who never smoked. The federally funded analysis of data on 15,000 patients in five large prospective studies shows that survivors of bladder, kidney, stage I lung and head and neck cancers who smoke 20 or more cigarettes a day prior to their cancer diagnosis are at an increased risk of developing second smoking-related cancers.

Nearly a Third of Patients with Cancer Experience Anxiety or Other Mental Health Challenges

One in three patients with cancer experiences anxiety or other mental health challenges, according to a study published in the Journal of Clinical Oncology. This is the largest and most comprehensive study to date assessing the mental and emotional health of patients with cancer using a standardized, diagnostic face-to-face interview.

2014 Breast Cancer Symposium Highlights on the Impact of Breast Cancer Screening Reminders, with Julia White, MD

The following is a transcript of a podcast led by Dr. Julia White, who discusses one study highlighted at the 2014 Breast Cancer Symposium that presents research on the impact of sending reminders to women overdue for breast cancer screening with mammography. Dr. White is Vice Chair of Clinical Research and Director of Breast Radiation Oncology in the Department of Radiation Oncology at the Ohio State University. Dr.

2014 Breast Cancer Symposium Highlights on the Impact of Angelina Jolie’s Story on Genetic Testing, with Harold Burstein, MD, PhD

The following is a transcript of a podcast led by Dr. Harold Burstein, who discusses one study highlighted at the 2014 Breast Cancer Symposium that presents research on the impact that Angelina Jolie’s choice of having surgery to prevent breast cancer had on genetic testing for genes linked to breast cancer risk. Dr.

New Immunotherapy, MK-3475, Shows Promise for Metastatic Melanoma

ASCO Annual Meeting
June 2, 2014

According to the results of a large phase I study, a new drug called MK-3475 may benefit people with melanoma that has spread to other parts of the body. MK-3475 blocks the function of a protein called PD-1 (programmed death-1) found on T-cells, a type of white blood cell that directly helps fight disease. Because PD-1 keeps the immune system from destroying cancer cells, stopping PD-1 from working allows the immune system to better eliminate melanoma.

Pages

Subscribe to RSS - Research Summaries